Spyre Therapeutics Inc. Tangible Net Worth Ratio
Spyre Therapeutics Inc. tangible net worth ratio. Spyre Therapeutics Inc. (SYRE) has a Tangible Net Worth Ratio of 100.0% as of June 2026. This metric is calculated by deducting intangible assets ($0.00) from net assets ($1.10 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See debt-free asset ratio of Spyre Therapeutics Inc. to measure how much of total assets are equity-financed.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Spyre Therapeutics Inc. (2013–2025)
Tangible net worth ratio of Spyre Therapeutics Inc. from 2013 to 2025. This chart shows how Spyre Therapeutics Inc.'s Tangible Net Worth Ratio has changed across 13 annual periods from 2013 to 2025. As of June 2026, the ratio stands at 100.0%, reflecting net assets of $1.10 Billion with intangible assets of $0.00 USD. See SYRE working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Spyre Therapeutics Inc. Tangible Net Worth Ratio by Year (2013–2025)
Spyre Therapeutics Inc. tangible net worth ratio by year from 2013 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Spyre Therapeutics Inc. from 2013 to 2025, covering 13 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see Spyre Therapeutics Inc. (SYRE) market capitalisation.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 100.0% | $715.24 Million | $0.00 | $777.78 Million | ▲ +0.0 pp |
| 2024 | 100.0% | $517.80 Million | $0.00 | $608.48 Million | ▲ +0.0 pp |
| 2023 | 100.0% | $184.02 Million | $0.00 | $341.86 Million | ▲ +0.0 pp |
| 2022 | 100.0% | $50.30 Million | $0.00 | $71.14 Million | ▲ +0.0 pp |
| 2021 | 100.0% | $83.94 Million | $0.00 | $109.93 Million | ▲ +0.0 pp |
| 2020 | 100.0% | $139.83 Million | $0.00 | $161.62 Million | ▲ +0.0 pp |
| 2019 | 100.0% | $60.08 Million | $0.00 | $83.18 Million | ▲ +0.0 pp |
| 2018 | 100.0% | $67.43 Million | $0.00 | $77.74 Million | ▲ +0.0 pp |
| 2017 | 100.0% | $50.34 Million | $0.00 | $56.08 Million | ▲ +0.0 pp |
| 2016 | 100.0% | $62.97 Million | $0.00 | $67.06 Million | ▲ +0.0 pp |
| 2015 | 100.0% | $36.10 Million | $0.00 | $38.65 Million | ▲ +0.0 pp |
| 2014 | 100.0% | $1.87 Million | $0.00 | $2.93 Million | ▲ +0.0 pp |
| 2013 | 100.0% | $3.19 Million | $0.00 | $4.60 Million | — |